|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
|
|---|---|---|
| Revenues | ||
| Cost of revenues | ||
| Gross profit | ||
| Selling expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Total operating expenses | ||
| Income from operation | ||
| Financial expenses, net | ||
| Other (loss)/income, net | ||
| Change in fair value of warrant liabilities | ||
| Income before income tax expenses | ||
| Income tax expenses | ||
| Net income | ||
| Other comprehensive income, net of tax: | ||
| Net change in foreign currency translation adjustment | ||
| Total comprehensive income | ||
| Earnings per ordinary share | ||
| Basic (in Dollars per share) | ||
| Diluted (in Dollars per share) | ||
| Weighted average number of ordinary shares outstanding* | ||
| Basic (in Shares) | ||
| Diluted (in Shares) |
Loading...
